Pharmaceutical

Filter

Current filters:

None

Popular Filters

6750 to 6774 of 7207 results

US Senators Burr and Coburn introduce legislation to reform FDA

19-04-2012

US Senators Richard Burr (Republican, North Carolina) and Tom Coburn (Republican, Oklahoma) this week…

BiotechnologyLegalNorth AmericaPharmaceuticalPoliticsRegulation

Daiichi Sankyo and Ranbaxy launch Sevikar in Romania

19-04-2012

Japanese drug major Daiichi Sankyo (TYO: 4568) and its majority-owned Indian subsidiary Ranbaxy Laboratories…

Cardio-vascularDaiichi SankyoEuropeGenericsMarkets & MarketingPharmaceuticalRanbaxy LaboratoriesSevikar

PhRMA welcomes US Congressional support for Pediatric Reauthorization ACT

19-04-2012

US trade group Pharmaceutical Research and Manufacturers of America (PhRMA) has welcomed the bipartisan…

LegalNorth AmericaPharmaceuticalRegulation

Roche will not extend its tender offer for Illumina

19-04-2012

In view of the apparent re-election of the incumbent directors of Illumina (Nasdaq: ILMN), a leading…

BiotechnologyIlluminaMergers & AcquisitionsPharmaceuticalRoche

Abbott beats forecasts as 1st-qtr sees strong sales and earnings growth

19-04-2012

US health care major Abbott Laboratories (NYSE: ABT) pleased investors yesterday, reporting better-than-expected…

Abbott LaboratoriesFinancialPharmaceutical

Health activists call for greater public return on EU health R&D spending and a turn to needs-driven innovation

18-04-2012

In a Policy Paper published yesterday, Health Action International (HAI) Europe and the Trans Atlantic…

BiotechnologyEuropeFinancialPharmaceuticalResearch

Bristol-Myers expands hepatitis C accord with Medivir and Janssen

18-04-2012

Swedish infectious disease drug developer Medivir AB (OMX: MVIR) said yesterday that its development…

Anti-viralsBristol-Myers SquibbdaclatasvirJanssenJohnson & JohnsonLicensingMedivirPharmaceuticalResearch

Intellect Neuro links with University to test potential Alzheimer's vaccine

18-04-2012

US neurological-focused drug developer Intellect Neurosciences (OTCBB: ILNS) has entered into a collaboration…

Intellect NeuroscienceNeurologicalPharmaceuticalResearchVaccines

Johnson & Johnson 1st-qtr earnings up 12.5% but sales flat

18-04-2012

US health care giant Johnson & Johnson (NYSE: JNJ) posted first-quarter 2012 financial results in line…

FinancialJohnson & JohnsonPharmaceutical

Towards a robust global framework for conduct and oversight of clinical trials in EU

18-04-2012

The European Medicines Agency has published the final reflection paper on ethical and good clinical practice…

BiotechnologyEuropePharmaceuticalRegulationResearch

NICE turns down Roche breast cancer drug Avastin, citing too many uncertainties

18-04-2012

UK drug watchdog the National Institute for Health and Clinical Excellence (NICE), said this morning…

AvastinEuropeOncologyPharmaceuticalPricingRegulationRoche

Forest Labs profit plunges as Lexapro loses patent

18-04-2012

US drugmaker Forest Laboratories (NYSE: FRX) that reported earnings per share equaled $0.72 in the fourth…

FinancialForest LaboratoriesPharmaceutical

Daiichi Sankyo debuts bone cancer drug Ranmark in Japan

17-04-2012

Following National Health Insurance price listing yesterday, Japanese drug major Daiichi Sankyo (TYO:…

AmgenAsia-PacificAstraZenecaBiotechnologyDaiichi SankyodenosumabMarkets & MarketingOncologyPharmaceuticalRanmark

Ground-breaking on new Novo Nordisk plant in Russia

17-04-2012

Danish insulin giant Novo Nordisk (NOV: N) broke ground yesterday on a new $100 million plant in Russia…

EuropeFinancialInsulinMarkets & MarketingNovo NordiskPharmaceutical

Drug shortages spur developments in neurometabolic treatments

17-04-2012

A prolonged gap in the neurology market following the shutdown of a Genzyme production facility is tempting…

BiotechnologyMarkets & MarketingNeurologicalPharmaceuticalRare diseasesResearch

US social media activity in health care viewed by PwC

17-04-2012

Social media is changing the nature of health care interaction, and health organizations that ignore…

Markets & MarketingNorth AmericaPharmaceutical

Merck & Co in potential $1 billion deal for cancer drug candidate vintafolide

17-04-2012

US drug giant Merck & Co (NYSE: MRK) has entered into an agreement to develop and commercialize Endocyte's…

BiotechnologyEndocyteetarfolatideLicensingMerck & CoOncologyPharmaceuticalvintafolide

Vanda gains rights to Lilly's NK-1 receptor antagonist

17-04-2012

USA-based Vanda Pharmaceuticals (Nasdaq: VNDA) said yesterday that it has acquired an exclusive worldwide…

Eli LillyLicensingNeurologicalPharmaceuticalVanda Pharmaceuticals

No proof of added benefit of Sativex, says German IQWiG

17-04-2012

In an early benefit assessment under to the German Act on the Reform of the Market for Medicinal Products…

AlmirallEuropeGW PharmaceuticalsNeurologicalPharmaceuticalPricingRegulationSativex

6750 to 6774 of 7207 results

Back to top